Concept and classification of dystonia.

Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group

Francesco Rodeghiero, Roberto Stasi, Terry Gernsheimer et al. · Blood · 2008 · 2.7K citations · Full text

Medicine, Hematology, Immunology +15

Eltrombopag for the Treatment of Chronic Idiopathic Thrombocytopenic Purpura

James B. Bussel, Gregory Cheng, Mansoor N. Saleh et al. · New England Journal of Medicine · 2007 · 805 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study

Gregory Cheng, Mansoor N. Saleh, Claus Werenberg Marcher et al. · The Lancet · 2010 · 582 citations · Full text

Medicine, Hematology, Pharmacotherapy +7

Phase 1 clinical study of eltrombopag, an oral, nonpeptide thrombopoietin receptor agonist

J.M. Jenkins, Daphne Williams, Yanli Deng et al. · Blood · 2007 · 299 citations

Medicine, Pharmacology, Pharmacotherapy +5

Preclinical Activity of Eltrombopag (SB-497115), an Oral, Nonpeptide Thrombopoietin Receptor Agonist

Connie L. Erickson‐Miller, Evelyne Delorme, Shin‐Shay Tian et al. · Stem Cells · 2008 · 286 citations · Full text

Medicine, Hematology, Pharmacology +15